D-serine (DrugBank: Serine, D-Serine)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00215904 (ClinicalTrials.gov) | August 2003 | 18/9/2005 | D-serine Adjuvant Treatment for Parkinson's Disease | D-serine Adjuvant Treatment for Parkinson's Disease | Parkinson's Disease | Drug: D-serine (~2g/day) | Herzog Hospital | NULL | Completed | 30 Years | 75 Years | Both | 13 | Phase 4 | Israel |